MedPath

Therapeutic evaluation and follow-up study of myasthenia gravis treated by integrated traditional chinese and western medicine based on the real world study

Not Applicable
Conditions
myasthenia gravis
Registration Number
ITMCTR1900002449
Lead Sponsor
The First Affiliated Hospital of Guangzhou University of Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

From August 2019 to December 2039, patients with myasthenia gravis were diagnosed in the outpatient and inpatient departments of the center.

Exclusion Criteria

None.

Study & Design

Study Type
Observational study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
the occurrence of myasthenic crisis during hospitalization and within 10 years;PRO scale;mortality;MGC grade;Glucocorticoid dosage;recurrence rate;ADL grade;Serum levels of inflammatory factors;
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath